Inseption Group
Inseption Group is a privately held clinical outsourcing organization serving emerging and mid-sized biotech and pharma sponsors. It provides FSP, full-service and deliverables-based clinical research engagements across rare disease, oncology, cell and gene therapy, and neurodegenerative programs.
- Company typePrivate
- Founded2011
- HeadquartersLansdale, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Inseption Group does
Inseption Group is a privately held, Pennsylvania-based clinical outsourcing organization serving emerging and mid-sized biotechnology and pharmaceutical sponsors. Founded in 2011 (per company history) and headquartered in Audubon, PA, the firm operates with 51-100 employees and runs a professional services model organized around three primary engagement constructs: Functional Service Provider (FSP) where embedded personnel become extensions of sponsor teams; Full-Service clinical trial outsourcing; and Deliverables-Based projects for defined outputs such as protocols, CSRs, IBs, audits and regulatory documents. Core functional coverage spans Clinical Operations, Site Management and Clinical Monitoring, Data Management, Drug Safety, Quality Assurance and Auditing, Medical Monitoring, Medical Writing and Quality Control, Biostatistics, Trial Master File Management, Regulatory Operations, Regulatory Affairs, and Contracts.
Underlying processes are anchored by the proprietary Cooperativity Program, a structured onboarding, mentoring and performance management framework designed to maintain low staff turnover (the firm reports <6% attrition overall and 0% turnover across a decade-long FSP engagement). The offering is differentiated along therapeutic depth rather than proprietary software: Inseption maintains specialized practices in rare/orphan disease, oncology (including CAR-T), neurodegenerative disorders, cell therapy, and gene therapy. A Clinical Trial Rescue solution and an IND planning/submission service address earlier-stage and troubled-program use cases, and a Strategic Consulting layer sits above functional delivery.
Revenue mechanics are quote-based across all three engagement models; pricing is not publicly disclosed. The go-to-market is sales-led and consultative, with enterprise field sales targeting sponsors directly, supported by content marketing (thought leadership articles, webinars, video interviews), an active LinkedIn presence, and PR. The company reports 100% of business from referrals or repeat clients and a majority of revenue from emerging and mid-sized biotech. Strategic positioning emphasizes transparency, talent stability, and therapeutic expertise as alternatives to large-volume commoditized CRO relationships.
Inseption Group firmographics
Firmographics- Name
- Inseption Group
- Legal name
- inSeption Group, LLC
- Website
- https://inseptiongroup.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Inseption Group is a privately held clinical outsourcing organization serving emerging and mid-sized biotech and pharma sponsors. It provides FSP, full-service and deliverables-based clinical research engagements across rare disease, oncology, cell and gene therapy, and neurodegenerative programs.
- Ownership category
- akta.pro rank
Inseption Group industry classification
Industry- Product category
- Clinical Research Services (Contract Research Organization)
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)
- akta.pro secondary industries
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Medical Writing & Clinical Documentation FSP (HLAGAOAC), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)
Keywords
Where Inseption Group is headquartered
LocationHeadquarters
- HQ city
- Lansdale
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Inseption Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Outsourcing Services: Full-service, FSP (Functional Service Provider), and deliverables-based clinical research services. Revenue is generated through professional service engagements with biotech and pharma companies across various engagement models including full-service outsourcing, functional service provider arrangements, and project-based deliverables.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
Inseption Group product offering
Product offeringCore offering
InSeption Group is a clinical outsourcing organization that provides biotech and pharmaceutical sponsors with outsourced clinical research services across the full clinical trial lifecycle. The company delivers these services through three engagement models — Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing — covering functional areas including Clinical Operations, Site Management & Clinical Monitoring, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, TMF Management, Regulatory Operations, Regulatory Affairs, and Contracts, with concentrated therapeutic expertise in rare/orphan diseases, oncology, neurodegenerative disorders, cell therapy, and gene therapy.
Product overview
Inseption Group is a clinical outsourcing organization offering a comprehensive suite of services across the clinical research lifecycle. The company provides functional services (Clinical Operations, Site Management, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, Regulatory Operations, Regulatory Affairs, and Contracts) through multiple engagement models including Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing. The portfolio includes specialized solutions for complex needs such as Clinical Trial Rescue Support, Investigational New Drug Applications, and Strategic Consulting, supported by the Cooperativity Program for structured onboarding. The company focuses on therapeutic areas including Rare/Orphan Disease, Oncology, Neurodegenerative Disorders, Cell Therapy, and Gene Therapy.
Differentiator
Problem solved
Functional benefit
Products and services
- Functional Service Provider (FSP) Embedded professional model providing clinical research experts who become extensions of sponsor teams, offering structure, continuity, and leadership within client organizations.
- Full Service Clinical Outsourcing Comprehensive clinical trial outsourcing solution providing specialized talent, under <6% employee attrition, and transparent cost structures for end-to-end trial execution.
- Deliverables-Based Outsourcing Project-based outsourcing for specific clinical deliverables such as protocols, CSRs, IBs, audits, and regulatory documents.
- Clinical Trial Rescue Support Strategic reinforcement services that address trial failures through targeted scaffolding rather than complete program overhaul.
- Investigational New Drug (IND) Applications IND planning, authoring, and submission services including strategic planning, regulatory pathway evaluation, and FDA communication for first-in-human trials.
- Strategic Consulting Advisory services for clinical development strategy, partner selection, and operational excellence.
- Cooperativity Program Structured onboarding, mentoring, and performance management program for integrating embedded professionals into client teams.
- Pre-IND Submission Training Training on the IND process, FDA expectations, strategic tips, and practical preparation tools for first-in-human trials.
- Clinical Operations Expert management and oversight of clinical trial activities including project management, operational planning, and cross-functional coordination.
- Site Management & Clinical Monitoring Comprehensive site management, end-to-end clinical monitoring, and monitoring oversight services.
- Data Management Collection, validation, and management of clinical trial data to ensure accuracy and regulatory compliance.
- Drug Safety / Pharmacovigilance Pharmacovigilance and drug safety operations including adverse event reporting and safety monitoring.
- Quality Assurance & Auditing Quality assurance services including clinical and vendor audits, gap assessments, CAPA plans, and inspection readiness support.
- Medical Monitoring Medical oversight of clinical trials ensuring patient safety and protocol compliance.
- Medical Writing & Quality Control Regulatory and medical documentation including protocols, CSRs, IBs, narratives, and IND/NDA module content with quality control.
- Biostatistics Statistical analysis services including SAP development and statistical support for clinical programs.
- Trial Master File (TMF) Management TMF structure, management, health checks, remediation, and inspection readiness.
- Regulatory Operations Technical regulatory submissions including eCTD submissions to the FDA through the ESG Gateway.
- Regulatory Affairs Regulatory strategy, FDA meeting support, briefing documents, and navigation of regulatory requirements.
- Contracts Contract development and vendor oversight services for clinical trial programs.
- Rare/Orphan Disease Clinical Expertise Specialized expertise in rare and orphan disease clinical trials.
- Oncology Clinical Expertise Specialized expertise in oncology clinical trials including CAR-T and cell therapy.
- Neurodegenerative Disorders Clinical Expertise Specialized expertise in neurodegenerative disorder clinical trials.
- Cell Therapy Clinical Expertise Specialized expertise in cell therapy clinical trials including autologous cell therapy.
- Gene Therapy Clinical Expertise Specialized expertise in gene therapy clinical trials.
Quantifiable outcome
- <6% employee attrition rate
- +2 more outcomes
Companies that use Inseption Group
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Inseption Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Inseption Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Pennsylvania Biotechnology Center (PABC)coreinSeption Group has partnered with the Pennsylvania Biotechnology Center (PABC) as the exclusive outsourcing partner for the PABC and B+Labs community. This strategic collaboration provides crucial strategic guidance and support to early-stage biotech companies in the PABC ecosystem, helping them navigate the complexities of early trial planning and development. The partnership aligns both organizations' missions to accelerate life sciences innovations and enhance support for emerging biotech companies, with inSeption delivering industry-leading expertise in clinical outsourcing.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Inseption Group competitors and assessment
Company assessmentDirect peers
- Medpace: Mid-sized, scientifically focused CRO with a comparable model of serving small-to-mid biotech and pharma sponsors with full-service clinical trial execution across multiple therapeutic areas. Medpace competes for many of the same emerging and mid-sized biotech mandates InSeption targets.
- Rho: Mid-sized CRO providing full-service clinical research, biostatistics, and regulatory services to emerging and mid-sized biopharma. Closely comparable in size, sponsor profile, and service breadth.
- Worldwide Clinical Trials: Mid-sized CRO concentrating on complex therapeutic areas including CNS, oncology, and rare diseases for small and mid-sized biopharma. Comparable to InSeption in therapeutic focus and mid-market sponsor positioning.
- Premier Research: Specialty CRO focused on small and mid-sized biopharma, with deep expertise in rare disease, oncology, neurology, and cell/gene therapy — a near-identical therapeutic profile to InSeption. Direct competitor for emerging biotech FSP and full-service engagements.
- Clinipace Worldwide (now CRIO): Mid-sized CRO with FSP and full-service offerings targeted at small-to-mid biotech sponsors, with overlapping functional service categories (data management, biostatistics, regulatory, clinical operations).
Broad incumbents
- IQVIA: Largest global CRO with comprehensive FSP, full-service, and technology-enabled offerings. Competes with InSeption for biotech outsourcing mandates but at vastly larger scale and with proprietary technology (e.g., E360, RBQM).
- Syneos Health: Large global CRO with biopharma services and FSP offerings. While much larger, Syneos' commercialized FSP model overlaps with InSeption's positioning for biotech sponsor embedded teams.
- ICON plc: Top-tier global CRO offering full-service and FSP across all therapeutic areas. Competes for emerging biotech work but serves a much broader sponsor base including large pharma; offers proprietary technology platforms InSeption does not.
Emerging players
- Caidya (formerly dMed|Biophinix): Mid-sized CRO focused on Asia-Pacific and global clinical operations for biotech sponsors, with growing presence in cell/gene therapy and oncology trials — therapeutic areas that overlap with InSeption's specialization.
- MMS Holdings: Data-focused clinical research organization providing biostatistics, statistical programming, data management, and regulatory services to biopharma. Partial overlap with InSeption's data management and biostatistics offerings, particularly for FSP engagements.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Inseption Group social profiles
Digital presenceInseption Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Inseption Group leadership team
Management profileNumber of profiles
Profiles3 records
Inseption Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Inseption Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Inseption Group
What does Inseption Group do?
InSeption Group is a clinical outsourcing organization that provides biotech and pharmaceutical sponsors with outsourced clinical research services across the full clinical trial lifecycle. The company delivers these services through three engagement models — Functional Service Provider (FSP), Full Service, and Deliverables-Based Outsourcing — covering functional areas including Clinical Operations, Site Management & Clinical Monitoring, Data Management, Drug Safety, Quality Assurance, Medical Monitoring, Medical Writing, Biostatistics, TMF Management, Regulatory Operations, Regulatory Affairs, and Contracts, with concentrated therapeutic expertise in rare/orphan diseases, oncology, neurodegenerative disorders, cell therapy, and gene therapy.
Is Inseption Group a public or private company?
Inseption Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Inseption Group founded?
Inseption Group was founded in 2011. It employs 51 to 100 people.
Where is Inseption Group based?
Inseption Group is headquartered in Lansdale, United States, in the North America region.
How does Inseption Group make money?
One revenue line is on record: clinical Outsourcing Services.
Who are Inseption Group's main competitors?
Direct peers on record are Medpace, Rho, Worldwide Clinical Trials, Premier Research and Clinipace Worldwide (now CRIO). Broad incumbents are IQVIA, Syneos Health and ICON plc. Emerging players are Caidya (formerly dMed|Biophinix) and MMS Holdings.
Does Inseption Group have an API?
No public API is recorded for Inseption Group.
What industry is Inseption Group in?
Inseption Group's product category is Clinical Research Services (Contract Research Organization). Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 54171 and its SIC code is 8731.